XASX
ONE
Market cap104mUSD
Jun 18, Last price
0.17AUD
1D
0.00%
1Q
-12.82%
Jan 2017
-97.32%
IPO
-95.56%
Name
Oneview Healthcare PLC
Chart & Performance
P/E
—
P/S
9.26
EPS
—
Div Yield, %
—
Shrs. gr., 5y
38.21%
Rev. gr., 5y
6.87%
Revenues
10m
+5.29%
Net income
-11m
L+21.28%
CFO
-10m
L-11.05%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Oneview Healthcare PLC, headquartered in Dublin, Ireland since its establishment in 2008, specializes in furnishing bespoke software and expert consulting services. These offerings are tailored for the global healthcare industry, with a presence spanning Ireland, the United States, Australia, Asia, and the Middle East. The company's core offerings revolve around its Care Experience Platform (CXP), which includes several distinct solutions: CXP Cloud Start: Designed to enable clients to seamlessly deploy essential digital engagement functionalities across their entire organizational footprint. CXP Cloud Enterprise: This solution empowers patients and their relatives to communicate virtually with healthcare providers, while also providing access to vital educational resources and health-related information. CXP Enterprise On-Prem: A robust on-premise offering engineered to address diverse institutional requirements, suitable for a wide range of facilities, from new construction projects to existing hospitals utilizing legacy infrastructure. Furthermore, Oneview Healthcare also provides specialized tools aimed at enhancing patient and family empowerment, optimizing the overall patient experience, facilitating remote virtual care delivery, and offering solutions like digital room signage and interactive patient communication boards.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||